References
- Kumar M, Kulkarni GT. Recent advances in ophthalmic drug delivery. Int J Pharm Sci 2012;4:387–394
- Gaudana R, Jwala J, Boddu SHS, Mitra KA. Recent perspectives in ocular drug delivery. Pharm Res 2009;26:1197–1216
- Rajas JN, Kavitha K, Gounder T, Mani T. In situ ophthalmic gels: a developing trend. Int J Pharm Sci Rev Res 2011;7:8–14
- Mohanambal E, Arun K, Abdul HSA. Formulation and evaluation of pH-triggered in situ gelling system of levofloxacin. Ind J Pharm Edu Res 2011;45:58–64
- Kashikar VS, Ophthalmic mucoadhesive polymers – a literature review of levofloxacin. Int J Pharm Edu Res 2011;7:68–73
- Zhidong LA, Jianier LB, Shufang NA, et al. Study of an alginate/HPMC based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12–17
- Gupta H, Aqil M, Khar KR, et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed Nanotechnol Biol Med 2010;6:324–333
- Thomas K, Patrichia B, Friedemann K. Treatment of patients with keratoconjunctivitis sicca with optive™: results of a multicenter, open-label observational study in Germany. Clin Ophthalmol 2009;3:33–39
- Johan C, Katarina E, Roger P, Katarina J. Rheological evaluation of gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 1998;6:113–119
- Sultana Y, Aqil M, Ali A. Ion activated Gelrite-based in situ ophthalmic gels of pefloxacinmesylate: comparison with conventional eye drops. Drug Deliv 2006;13:215–219
- Gupta D, Tator, HC, Shoichet SM. Fast gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the spinal cord. Biomaterials 2006;27:2370–2379
- Eaga CM, Jagan MK, Venkatesh A. Preparation and evaluation of in situ gels for ocular drug delivery. J Pharm Res 2009;2:1089–1094
- Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH-triggered in situ gelling system. J Control Rel 2001;73:205–211
- Gupta H, Jain S, Mathur R, et al. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv 2007;14:507–515
- Rathore SM, Majumdar KD. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous eye drops. AAPS PharmSciTech 2006;7:E1–E6
- Charoo NA, Kohli K, Ali A. Preparation of in situ forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies. J Pharm Sci 2003;92:407–415
- Gilleron L, Coecke S, Sysmans S, et al. Evaluation of a modified HET-CAM assay as a screening test for eye irritancy. Toxicol In Vitro 1996;10:431–446
- Sindhu A, Sharon F, Bharath S, et al. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Pak J Pharm Sci 2009;22:175–179
- Ahad A, Aqil M, Kohli K, et al. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed Nanotechnol Biol Med 2012;8:237–249
- Stahlmann R, Zippel U, Forster C, et al. Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats. Antimicrob Agents Chemother 1998;42:1470–1475
- ICH Topic Q 1 A (R2), Stability Testing of new Drug Substances and Products CPMP/ICH/2736/99, August 2003
- Liu Z, Li J, Nie S, et al. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12–17